SAN FRANCISCO — Fluxion Biosciences, a leading developer of automated solutions for cellular analysis in life sciences research and drug discovery, today announced that it has signed a distribution agreement with Harvard Biosciences. The https://www.baratron.com/ – photo distribution agreement covers Fluxion’s BioFlux™ and IonFlux™ platforms for sale to Harvard Bioscience’s customers in North America. Fluxion’s BioFlux system is […]

Award to Chinese Scientist Supports the Use of Various Molecular Approaches to Cancer Research SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced that Professor Jiandong Jiang has received an Agilent Thought Leader Award in support of his studies on cancer stem cells differentiation induced by natural products. “Cancer is a chronic disease generated […]

Labcyte Inc. and the Institute for Molecular Medicine Finland (FIMM), a unit of the Helsinki Institute of Life Science at the University of Helsinki today announced they are extending their personalized medicine collaboration to include multiple new applications that leverage the unique capabilities of Labcyte’s Echo® Liquid Handler and Access™ Automation platform. The organizations first […]

Expanded data acquisition and analysis capabilities added to gold-standard software for patch-clamp experiments SUNNYVALE, Calif. Molecular Devices, LLC, a leader in protein and cell biology technologies, announced the launch of the newest generation of its widely-used data acquisition and analysis software for patch-clamp electrophysiology, pCLAMP™ Software Suite Version 11 today. Among many new features, this […]

America’s Seed Fund Powered by NSF Provides Funding for R&D; Helps small businesses move innovations out of the lab and into the market StabiLux Biosciences has been awarded a National Science Foundation (NSF) Small Business Technology Transfer (STTR) Phase II grant for $600,000 to commercialize innovative technology by conducting research and development (R&D) work on […]

Innovative animal-free cell culture improves consistency, safety and efficiency  Berlin, Germany – InVitria, a division of Ventria Bioscience, has announced the launch of a new media formulation service at the international BIO-Europe conference in Berlin, Germany. Leveraging Ventria’s proprietary ExpressTec technology, InVitria has developed and commercialized eight recombinant proteins and cell culture media supplements made in a completely animal-free system. Animal-component […]

SAN DIEGO — Organovo Holdings, Inc.(NASDAQ:ONVO) (“Organovo”) and Viscient Biosciences (“Viscient”) today announced a collaboration to develop a custom research platform for studying liver disease.  The partnership is expected to expand upon Organovo’s current service portfolio for compound screening in disease models, which aids the drug discovery work of the Company’s customers.  Viscient is targeting early […]

Walkersville, MD (USA) / Basel (CH) – Today Lonza Walkersville announced its new offering of Silensomes™ Human Liver Microsomes (HLM) products – pooled human liver microsomes for in vitro cytochrome P450 (CYP) phenotyping. CYP phenotyping is a regulatory requirement for new drug candidates to understand their metabolism and to predict drug-drug interactions. Lonza Walkersville’s new Silensomes™ HLM products provide […]

Collaboration aimed at developing novel “Nephron-on-a-Chip” device to test drug candidates in human kidney: NEPLEX (“NEPHRON-ON-A-CHIP WITH CELLULAR AND EXTRACELLULAR MATRIX COMPLEXITY”) Major step forward to the next generation kidney platform Hamburg, Germany: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced a strategic collaboration on microfluidics technology including induced pluripotent stem cell […]

As of October 2017 Micronit, Axxicon and Helvoet are collaborating in offering a market leading  development and manufacturing package to support the growing global demand for high volume polymer microfluidic products.  The strong market growth is driven by the new fast diagnostic systems being developed and entering the health care market. At the same time […]